Literature DB >> 6092405

An endogenous ouabain-like factor associated with hypertensive pregnant women.

S W Graves, G H Williams.   

Abstract

Levels of a ouabain-like factor (OLF) were measured in amniotic fluid from 49 undigitalized third trimester pregnant women by means of its cross-reactivity in a digoxin RIA and its inhibition of ouabain-sensitive [Na,K]ATPase. The results from these 2 assays were significantly correlated (P less than 0.05). Of the women included in this study, 25 had blood pressures considered normal for their gestational age, while 24 had developed during their current pregnancy blood pressures judged to be elevated. When levels of OLF in the amniotic fluids from the normotensive and hypertensive pregnant women were compared, significantly higher levels were present in the hypertensive group for both assays (P less than 0.002). Further, there was a significant correlation between the diastolic blood pressures of these women at the time of amniocentesis and the amniotic fluid OLF levels determined by either assay (P less than 0.002). These results are consistent with OLF having a role in hypertensive complications of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092405     DOI: 10.1210/jcem-59-6-1070

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

2.  Normal pregnancy: mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressure.

Authors:  Brandiese E Jacobs; Yong Liu; Maria V Pulina; Vera A Golovina; John M Hamlyn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-13       Impact factor: 4.733

Review 3.  Sodium transport inhibitors in pregnancy-induced hypertension.

Authors:  L Poston
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

4.  Digoxin immune fab protects endothelial cells from ouabain-induced barrier injury.

Authors:  Yuping Wang; Ruping Fan; Yang Gu; C David Adair
Journal:  Am J Reprod Immunol       Date:  2011-07-12       Impact factor: 3.886

5.  Further evidence for the dissociation of digoxin-like immunoreactivity from Na+,K(+)-ATPase inhibitory activity.

Authors:  K Yamada; A Goto; M Ishii; M Yoshioka; T Sugimoto
Journal:  Experientia       Date:  1990-10-15

6.  Digibind attenuates cytokine TNFalpha-induced endothelial inflammatory response: potential benefit role of digibind in preeclampsia.

Authors:  Y Wang; D F Lewis; C D Adair; Y Gu; L Mason; J H Kipikasa
Journal:  J Perinatol       Date:  2009-01-15       Impact factor: 2.521

7.  Endogenous sodium pump inhibitors, diabetes mellitus and preeclampsia Preliminary observations and a hypothesis.

Authors:  Yakov Y Bagrov; Natalia B Manusova; Elena V Frolova; Irina A Egorova; Vladimir A Kashkin; Natalia I Tapilskaya; Olga V Fedorova; Alexei Y Bagrov
Journal:  Pathophysiology       Date:  2007-10-17

8.  Synthetic Receptors Induce Anti Angiogenic and Stress Signaling on Human First Trimester Cytotrophoblast Cells.

Authors:  Ahmed F Pantho; Mason Price; Ahm Zuberi Ashraf; Umaima Wajid; Maryam Emami Khansari; Afsana Jahan; Syeda H Afroze; Md Mhahabubur Rhaman; Corey R Johnson; Thomas J Kuehl; Md Alamgir Hossain; Mohammad Nasir Uddin
Journal:  Int J Environ Res Public Health       Date:  2017-05-11       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.